Elisabeth J Rushing Selected Research

Elisabeth J Rushing Research Topics

Disease

37	Neoplasms (Cancer) 01/2023 - 08/2003
9	Glioma (Gliomas) 01/2023 - 06/2008
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2012
6	Astrocytoma (Pilocytic Astrocytoma) 12/2013 - 05/2003
4	Brain Neoplasms (Brain Tumor) 01/2023 - 09/2009
4	Meningioma (Meningiomas) 12/2021 - 04/2007
4	Medulloblastoma 05/2018 - 07/2009
3	Muscular Diseases (Myopathy) 03/2021 - 04/2013
3	Oligodendroglioma 11/2020 - 05/2003
3	Melanoma (Melanoma, Malignant) 01/2019 - 08/2009
3	Ependymoma 04/2016 - 06/2005
3	Carcinogenesis 08/2010 - 04/2007
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
2	Communicable Diseases (Infectious Diseases) 01/2019 - 11/2008
2	Chordoma 01/2019 - 01/2011
2	Lymphoma (Lymphomas) 01/2018 - 09/2008
2	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 04/2017
2	Infections 01/2017 - 05/2015
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2017 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 05/2015
2	Neurofibromatoses (Neurofibromatosis) 12/2013 - 12/2011
2	HIV Infections (HIV Infection) 06/2012 - 11/2008
2	Residual Neoplasm 08/2010 - 08/2003
2	Mesenchymal Chondrosarcoma 05/2010 - 02/2010
2	Immune Reconstitution Inflammatory Syndrome 11/2008 - 08/2008
1	Venous Thromboembolism 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 03/2021
1	Keratoconus 03/2021
1	Bethlem myopathy 03/2021
1	Inflammation (Inflammations) 01/2019
1	Hyperplasia 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2017
1	Intellectual Disability (Idiocy) 01/2017

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2005
4	Phosphotransferases (Kinase)IBA 01/2022 - 08/2014
4	ParaffinIBA 09/2012 - 05/2003
3	AntigensIBA 12/2022 - 07/2009
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2012
3	PrionsIBA 01/2019 - 05/2015
3	ErbB Receptors (EGF Receptor)IBA 08/2014 - 06/2008
3	Transcription Factors (Transcription Factor)IBA 08/2014 - 02/2010
3	S100 Proteins (S 100 Protein)IBA 01/2012 - 06/2005
3	Keratins (Keratin)IBA 02/2010 - 06/2005
2	LigandsIBA 01/2023 - 06/2011
2	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2022 - 01/2013
2	CollagenIBA 03/2021 - 01/2011
2	MethyltransferasesIBA 01/2021 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 08/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 02/2010
2	Messenger RNA (mRNA)IBA 01/2017 - 07/2009
2	Prion ProteinsIBA 01/2017 - 01/2016
2	Carmustine (FIVB)FDA Link 08/2015 - 08/2008
2	CytokinesIBA 08/2014 - 01/2011
2	Mitogen-Activated Protein KinasesIBA 12/2013 - 09/2012
2	Formaldehyde (Formol)FDA Link 09/2012 - 04/2007
2	Immunoglobulin G (IgG)IBA 03/2012 - 07/2009
2	Melanins (Melanin)IBA 01/2012 - 09/2009
2	Retinaldehyde (Retinal)IBA 01/2012 - 09/2006
2	VimentinIBA 01/2012 - 07/2008
2	GadoliniumIBA 01/2012 - 11/2009
2	Dihydrotachysterol (AT 10)IBA 12/2011 - 11/2004
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2010 - 06/2008
2	Mucin-1 (CA 15-3 Antigen)IBA 07/2008 - 06/2005
2	SynaptophysinIBA 07/2008 - 04/2007
2	Glial Fibrillary Acidic ProteinIBA 04/2007 - 06/2005
1	Cell Adhesion MoleculesIBA 01/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	dipinacoline glutamateIBA 01/2023
1	somatostatin receptor 2IBA 12/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	vinyltriethoxysilane (VTES)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Activin Receptors (Activin Receptor)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	O-(6)-methylguanineIBA 01/2021
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 12/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2020
1	Tyrosine (L-Tyrosine)FDA Link 11/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	A 19IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Brachyury protein (Brachyury)IBA 01/2019
1	IntegrinsIBA 05/2018
1	SteroidsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018
1	Bevacizumab (Avastin)FDA Link 10/2017
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 04/2017

Therapy/Procedure

15	Therapeutics 01/2022 - 08/2003
13	Radiotherapy 12/2020 - 08/2003
10	Drug Therapy (Chemotherapy) 01/2021 - 08/2003
1	Chemoradiotherapy 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Extracorporeal Membrane Oxygenation 11/2017